Accendra Health Finalizes Major Debt Exchange, Secures $539M First Lien Notes & $300M Revolver
Summary
Accendra Health announced the successful early results of its debt exchange offers, achieving near-full participation, and finalized terms for $539.25 million in new First Lien Notes and a $300 million revolving credit facility, significantly strengthening its balance sheet.
Key Events
-
Successful Debt Exchange Offers
The company announced early results for its debt exchange offers, with approximately $478.3 million (99.9%) of 2029 Notes and $547.9 million (99.2%) of 2030 Notes tendered, indicating strong creditor participation in the restructuring.
-
New First Lien Notes Issued
Accendra Health issued $539.25 million in 9.000% Senior Secured First Lien Notes due 2032, comprising $213.0 million from the debt exchange and $326.25 million from a new money offering.
-
New Second Lien Notes Issued
The company issued $698.0 million in 9.750% Senior Secured Second Lien Notes due 2033 as part of the debt exchange for existing notes.
-
New Revolving Credit Facility Established
A new $300.0 million revolving credit facility due 2030 was established, providing additional liquidity and subject to specific leverage and interest coverage covenants.
Analysis
This 8-K provides crucial updates on Accendra Health's previously announced comprehensive balance sheet optimization. The near-complete participation in the debt exchange offers (99.9% of 2029 Notes and 99.2% of 2030 Notes) is a significant positive, indicating strong creditor support and successful execution of the restructuring plan. The issuance of $539.25 million in new First Lien Notes (including $326.25 million in new money) and $698.0 million in Second Lien Notes, alongside a new $300 million revolving credit facility, substantially improves the company's liquidity and extends its debt maturity profile. The waiver of mandatory prepayment provisions for $400 million in asset sales also provides greater financial flexibility. These actions are vital for the company's stability and ability to operate, especially given its prior reported Q1 loss and declining revenue.
At the time of this filing, ACH was trading at $3.03 on NYSE in the Trade & Services sector, with a market capitalization of approximately $232M. The 52-week trading range was $1.84 to $9.55. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.